Beyond antibiotics—a paradigm shift toward bacteria-control-centric therapies
Antimicrobial resistance is one of the world's most alarming public health challenges because multidrug-resistant (MDR) gram-negative bacteria increasingly render even last-line antibiotics ineffective, leading to substantially higher mortality rates. Polymyxins are a class of an